Cuorips Inc.

2026/07/28 Updated
Market Cap: $211.7M (¥34.6B)
Stock Price: $25.63 (¥4,195)
Exchange Rate: 1 USD = ¥163.67

Upward Revision of Full-Year Earnings Forecast | July 2026

Qualips has revised its full-year consolidated earnings forecast for the fiscal year ending March 2027 upward, projecting sales of 540 million yen and net profit of 570 million yen. The adjustments are due to the reimbursement price decision for Rehart and related insurance claims, resulting in improved sales and profits.

Importance:
Page Updated: July 28, 2026
IR Disclosure Date: July 28, 2026

Key Figures

  • Sales: 540 million yen
  • Net income attributable to owners of parent: △69.01 million yen
  • Operating profit: △1,030 million yen

AI要約

Performance Overview

Qualips has revised its full-year consolidated earnings forecast for the fiscal year ending March 2027 upward, with projected sales of 540 million yen and net income attributable to owners of parent of △69.01 million yen. The revisions reflect improved sales and profits driven by the reimbursement price decision for Rehart and subsidies received, with a reduction in operating loss.

Future Outlook and Impact

The reimbursement price decision for Rehart has clarified sales outlooks, with expected sales increases following the product's launch after September 2026. Subsidies received are also contributing to profit improvements, and these factors are anticipated to be significant in future business development.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Qualips Corporation

Company overview · Stock price · Financial data · All IR

View company page →